Indicated for the treatment of primary and secondary carnitine deficiency in adults, children, infants and neonates. Secondary carnitine deficiency in haemodialysis patients. Secondary carnitine deficiency should be suspected in long-term haemodialysis patients who have the following conditions: 1. Severe and persistent muscle cramps and/or hypotensive episodes during dialysis. 2. Lack of energy causing a significant negative effect on the quality of life. 3. Skeletal muscle weakness and/or myopathy. 4. Cardiomyopathy. 5. Anaemia of uraemia unresponsive to or requiring large doses of erythropoietin. 6. Muscle mass loss caused by malnutrition.
Indicated for the treatment of primary and secondary carnitine deficiency in adults and children over 12 years of age.
Background: Patient-reported outcomes (PROs) are important when evaluating treatment benefits in rheumatoid arthritis (RA).